Cargando…
Right on target: The next class of efficient, safe, and specific RNAi triggers
Autores principales: | Becker, Jonas, Fischer, Nico, Grimm, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035382/ https://www.ncbi.nlm.nih.gov/pubmed/35505965 http://dx.doi.org/10.1016/j.omtn.2022.03.027 |
Ejemplares similares
-
The Business of RNAi Therapeutics in 2012
por: Haussecker, Dirk
Publicado: (2012) -
Paving the way to a new class of efficient and safe tuberculosis vaccines: The role of c-di-AMP in Mycobacterium tuberculosis immunity and virulence
por: El Zowalaty, Mohamed E., et al.
Publicado: (2022) -
MicroRNAs that interfere with RNAi
por: Massirer, Katlin B., et al.
Publicado: (2013) -
Combinatorial RNAi: A Winning Strategy for the Race Against Evolving Targets?
por: Grimm, Dirk, et al.
Publicado: (2007) -
Endogenous RNAi and adaptation to environment in C. elegans
por: Grishok, Alla
Publicado: (2012)